237 related articles for article (PubMed ID: 35038313)
1. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
3. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
[TBL] [Abstract][Full Text] [Related]
4. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
[TBL] [Abstract][Full Text] [Related]
5. Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism.
Cinque L; Sparaneo A; Penta L; Mencarelli A; Rogaia D; Esposito S; Fabrizio FP; Baorda F; Verrotti A; Falorni A; Stangoni G; Hendy GN; Guarnieri V; Prontera P
J Clin Endocrinol Metab; 2017 Nov; 102(11):3961-3969. PubMed ID: 28938448
[TBL] [Abstract][Full Text] [Related]
6. Five patients with disorders of calcium metabolism presented with GCM2 gene variants.
García-Castaño A; Madariaga L; Gómez-Conde S; Cordo CLR; López-Iglesias M; Garcia-Fernández Y; Martín A; González P; Goicolea I; de Nanclares GP; De la Hoz AB; Aguayo A; de LaPiscina IM; Martínez R; Saso L; Urrutia I; Velasco O; Castaño L; Gaztambide S
Sci Rep; 2021 Feb; 11(1):2968. PubMed ID: 33536578
[TBL] [Abstract][Full Text] [Related]
7. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members.
Tomar N; Bora H; Singh R; Gupta N; Kaur P; Chauhan SS; Sharma YD; Goswami R
Eur J Endocrinol; 2010 Feb; 162(2):407-21. PubMed ID: 19940031
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism.
Bowl MR; Mirczuk SM; Grigorieva IV; Piret SE; Cranston T; Southam L; Allgrove J; Bahl S; Brain C; Loughlin J; Mughal Z; Ryan F; Shaw N; Thakker YV; Tiosano D; Nesbit MA; Thakker RV
Hum Mol Genet; 2010 May; 19(10):2028-38. PubMed ID: 20190276
[TBL] [Abstract][Full Text] [Related]
9. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism.
Yi HS; Eom YS; Park IeB; Lee S; Hong S; Jüppner H; Mannstadt M; Lee S
Clin Endocrinol (Oxf); 2012 May; 76(5):625-33. PubMed ID: 22066718
[TBL] [Abstract][Full Text] [Related]
11. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study.
Maret A; Ding C; Kornfield SL; Levine MA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1426-32. PubMed ID: 18182452
[TBL] [Abstract][Full Text] [Related]
13. A Knock-In Mouse Model of the
Parekh VI; Brinster LR; Guan B; Simonds WF; Weinstein LS; Agarwal SK
J Endocr Soc; 2023 Oct; 7(11):bvad126. PubMed ID: 37885910
[TBL] [Abstract][Full Text] [Related]
14.
Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
[TBL] [Abstract][Full Text] [Related]
15. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.
Grigorieva IV; Mirczuk S; Gaynor KU; Nesbit MA; Grigorieva EF; Wei Q; Ali A; Fairclough RJ; Stacey JM; Stechman MJ; Mihai R; Kurek D; Fraser WD; Hough T; Condie BG; Manley N; Grosveld F; Thakker RV
J Clin Invest; 2010 Jun; 120(6):2144-55. PubMed ID: 20484821
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
[TBL] [Abstract][Full Text] [Related]
17. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
18. Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
Correa P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):501-5. PubMed ID: 12354132
[TBL] [Abstract][Full Text] [Related]
19. Familial Hyperparathyroidism.
Blau JE; Simonds WF
Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
